In a report released yesterday, Sam Slutsky from LifeSci Capital maintained a Buy rating on Immunic, with a price target of $56.00.Claim 55% Off...

In a report released today, Charles Zhu from LifeSci Capital maintained a Buy rating on Immunome, with a price target of $40.00.Claim 55% Off Ti...

In a report released yesterday, Sam Slutsky from LifeSci Capital maintained a Buy rating on Immunic, with a price target of $56.00.Claim 55% Off...